Atrial Natriuretic Factor - Fetal Blood Volume Regulation

Silberbach, Gary Michael

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 5K08HD001051-03
• Application #: 2194602
• Study Section: Maternal and Child Health Research Committee (HDMC)
• Project Start: 1993-12-09
• Project End: 1998-11-30
• Budget Start: 1995-12-01
• Budget End: 1996-11-30
• Support Year: 3
• Fiscal Year: 1996

Institution

• Name: Oregon Health and Science University
• Department: Pediatrics
• Type: Schools of Medicine
• DUNS #: 009584210
• City: Portland
• State: OR
• Country: United States
• Zip Code: 97239

Publications

Silberbach, M; Gorenc, T; Hershberger, R E et al. (1999) Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem 274:24858-64

Silberbach, M; Woods, L L; Hohimer, A R et al. (1995) Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Pediatr Res 38:722-8

Silberbach, M; Anderson, D F; Reller, M D et al. (1994) Effect of atrial natriuretic peptide on vascular permeation in the ovine fetus. Pediatr Res 35:555-9